Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
LOADING
|||
Stockholders Equity Over Time
Above historical average, strong compound growth.
Left:
||||
Net worth of the company (assets minus liabilities)
Latest
$16.41B
↑ 102% above average
Average (9y)
$8.13B
Historical baseline
Range
High:$17.58B
Low:$939.97M
CAGR
+37.4%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $16.41B | -6.7% |
| 2023 | $17.58B | +26.4% |
| 2022 | $13.91B | +37.7% |
| 2021 | $10.10B | +16.3% |
| 2020 | $8.69B | +42.8% |
| 2019 | $6.09B | +37.2% |
| 2018 | $4.44B | +118.6% |
| 2017 | $2.03B | +75.4% |
| 2016 | $1.16B | +23.0% |
| 2015 | $939.97M | - |